Healthcare Industry Updates 3D Cell Culture Market | Global Growth Insights | Page 3

attributed to the ability of scaffold-based products to mimic in vivo conditions, thus driving
their adoption among end users.
Based on applications, the cancer and stem cell research segment is projected to grow at the
highest CAGR during the forecast period.
By applications, the 3D Cell Culture Market is segmented into cancer and stem cell research,
drug discovery and toxicology testing, and tissue engineering and regenerative medicine. The
cancer and stem cell research segment is expected to register the highest CAGR during the
forecast period. The increasing incidence of cancer and significant funding initiatives for cancer
research from government as well as private organizations are supporting the growth of this
application segment.
North America to dominate the 3D Cell Culture Market
In 2017, North America is expected to dominate the market followed by Europe. The large
share of this geographical segment is attributed to factors such as increasing incidence of
cancer, presence of a well-established pharmaceutical and biotechnology industry, significant
support from the government in the form of funds and grants, availability of technologically
advanced products, and presence of key market players.
The 3D Cell Culture Market is highly competitive with the presence of several small and big
players. Some of the players in the 3D Cell Culture Market include Thermo Fisher (US), Corning
(US), Lonza (Switzerland), Merck (Germany), ReproCELL (Japan), and InSphero (Switzerland).
The other players operating in this market include Global Cell Solutions (US), Synthecon (US),
3D Biotek (US), Kuraray (Japan), Hamilton Company (US), Mimetas (Netherlands), Emulate (US),
Nano3D Biosciences (US), and QGel (Switzerland).
Request Free Sample Pages: CLICK HERE